Efficacy of Topical Metformin 30% Versus Minoxidil 5% in the Treatment of Alopecia Areata : Comparative Study
This study aims to evaluate and compare the effectiveness and safety of topical metformin 30% and topical minoxidil 5% in patients with alopecia areata.
Alopecia areata is an autoimmune condition that causes non-scarring hair loss, usually presenting as round or oval patches on the scalp. Different topical treatments are used to stimulate hair regrowth, but their effectiveness varies.
In this comparative interventional study, eligible patients with alopecia areata will receive either topical metformin 30% or topical minoxidil 5%. Treatment response will be assessed clinically during follow-up using standardized assessment methods, including the Severity of Alopecia Tool (SALT) score, along with clinical and dermoscopic evaluation.
The study aims to determine whether topical metformin 30% is an effective treatment option compared with topical minoxidil 5% in patients with alopecia
研究概览
地位
地位
干预/治疗
干预/治疗
研究类型
研究类型
注册 (估计的)
注册
阶段
阶段
- 不适用
联系人和位置
学习地点
-
-
Sohag Governorate
-
Sohag、Sohag Governorate、埃及
- 招聘中
- Sohag University Hospital
-
接触:
- Arwa Ahmed Mohamed
- 电话号码:01026599979
- 邮箱:Arwasoltan@hotmail.com
-
-
参与标准
资格标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Patients aged above 18 years to 40 years
- Both sexes.
- Patients with a clinical and dermoscopic diagnosis of localized alopecia areata.
Exclusion Criteria:
- Patients who received systemic or topical treatment for alopecia areata during the previous three months before the start of the study.
- Pregnant or lactating women.
- Patients with bleeding or coagulation disorders.
- Patients with autoimmune diseases.
- Patients with liver or renal diseases.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
手臂数量
武器和干预
参与者组/臂参与者组/臂 |
干预/治疗干预/治疗 |
|---|---|
|
实验性的:Topical Metformin 30%
Participants assigned to this arm will receive topical metformin 30% for the treatment of alopecia areata. |
Topical metformin 30% preparation used for the treatment of alopecia areata. |
|
有源比较器:Topical Minoxidil 5%
Participants assigned to this arm will receive topical minoxidil 5% for the treatment of alopecia areata. |
Topical minoxidil 5% preparation used for the treatment of alopecia areata. |
研究衡量的是什么?
主要结果指标
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in SALT Score from Baseline to Week 12
大体时间:Baseline to Week 12 (12 weeks)
|
Assessment of the change in Severity of Alopecia Tool (SALT) score from baseline to week 12 to evaluate the therapeutic response to topical metformin 30% compared with topical minoxidil 5%. A decrease in SALT score indicates improvement in scalp hair loss. |
Baseline to Week 12 (12 weeks)
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
学习开始
初级完成 (估计的)
初级完成
研究完成 (估计的)
研究完成
研究注册日期
首次提交
首次提交
首先提交符合 QC 标准的
首先提交符合 QC 标准的
首次发布 (实际的)
首次发布
研究记录更新
最后更新发布 (实际的)
最后更新发布
上次提交的符合 QC 标准的更新
上次提交的符合 QC 标准的更新
最后验证
最后验证
更多信息
与本研究相关的术语
其他研究编号
其他研究编号
- Soh-Med-26-10-4MS
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.